Core Insights - The article discusses the breakthrough of PerturbDiff, a new AI model developed by the Mila team, which addresses the challenges of predicting drug responses in single-cell genomics by treating the distribution of cell populations as a random variable rather than relying on paired single-cell data [1][3][28]. Group 1: Model Innovation - PerturbDiff has achieved state-of-the-art (SOTA) results in predicting single-cell responses by utilizing a novel approach that models the distribution of cell populations instead of individual cells [3][28]. - The model incorporates a concept of "functional diffusion," allowing it to operate in a high-dimensional function space, which is essential for accurately representing the variability in biological responses [10][12]. Group 2: Theoretical Foundations - The model challenges the static assumptions of previous methods, which treated drug response distributions as fixed, highlighting the dynamic nature of biological systems influenced by various unseen variables [4][6]. - PerturbDiff employs advanced mathematical tools such as Reproducing Kernel Hilbert Space (RKHS) and Kernel Mean Embedding (KME) to effectively model complex population dynamics [9][11]. Group 3: Performance Metrics - PerturbDiff has demonstrated superior performance in multiple evaluations, including the Tahoe100M dataset, achieving high accuracy in predicting differential expression genes (DEGs), which are critical for assessing drug effects [18][20]. - The model's ability to generalize from limited data has been enhanced through marginal pretraining on a large dataset of unperturbed single-cell transcriptomes, leading to significant improvements in low-data scenarios [22][25]. Group 4: Biological Implications - The insights gained from the model's performance suggest that biological perturbations are not random but follow specific trajectories within existing cellular state manifolds, providing a deeper understanding of cellular responses to drugs [26][28]. - The development of PerturbDiff represents a significant step towards creating an ultimate "AI virtual cell" capable of accurately simulating perturbation responses, which could revolutionize drug discovery and development processes [29].